SCHEMBL28215599

SCHEMBL28215599

CC(C)n1c(Cl)cc2cc(C=O)ccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.46
PTGER4 P35408 2/20 0.40
ALDH1A1 P00352 4/20 0.39
TYR P14679 1/20 0.39
ALDH1A3 P47895 4/20 0.35
HSD17B10 Q99714 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH3A1 P30838 2/20 0.33
MAPT P10636 2/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
VCAM1 P19320 1/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 1/20 0.32
PTGS2 P35354 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28812822 0.78 CYP2A6 (0.54) CYP2A6PTGER4ALDH1A1TYRALDH1A3
SCHEMBL8687281 0.74 PTGER4 (0.49) CYP2A6PTGER4ALDH1A1TYRALDH1A3
SCHEMBL28215043 0.72 MAPT (0.33) HSD17B10MAPTTHRBMEN1HPGD
SCHEMBL15970954 0.71 CYP2A6 (0.64) CYP2A6PTGER4ALDH1A1TYRALDH1A3
SCHEMBL4728764 0.68 MEN1 (0.56) PTGER4ALDH1A1MAPTMEN1KMT2A
SCHEMBL27688161 0.68 CYP2A6 (0.46) CYP2A6PTGER4TYR
SCHEMBL14690041 0.68 ALDH1A1 (0.41) CYP2A6PTGER4ALDH1A1TYRALDH1A3
SCHEMBL15970760 0.67 PTGER4 (0.46) CYP2A6PTGER4ALDH1A1TYRALDH1A3
SCHEMBL28833063 0.66 CYP2A6 (0.56) CYP2A6ALDH1A1HSD17B10MAPTTHRB
SCHEMBL14270984 0.65 TYR (0.63) CYP2A6ALDH1A1TYRALDH1A3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105051037-B Sphingosine-1-phosphate receptor agonists, method for the preparation thereof and pharmaceutical compositions comprising the same as active agent LG化学株式会社 2018-05-18 CN disclosed